BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nappo G, Donisi G, Zerbi A. Borderline resectable pancreatic cancer: Certainties and controversies. World J Gastrointest Surg 2021; 13(6): 516-528 [PMID: 34194610 DOI: 10.4240/wjgs.v13.i6.516]
URL: https://www.wjgnet.com/1948-5204/full/v13/i6/516.htm
Number Citing Articles
1
Marco Massani, Tommaso Stecca. Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancerFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138587
2
Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligenceThe British Journal of Radiology 2022; 95(1137) doi: 10.1259/bjr.20220072
3
Anna Silvia Wenning, Christoph O. Ryser, Andreas Andreou, Beat Gloor, Martin D. Berger. Neues zur Therapie des Pankreaskarzinoms: Hoffnung am Horizont?Schweizer Gastroenterologie 2021; 2(4): 138 doi: 10.1007/s43472-021-00054-y
4
Gunjan Desai, Prasad K. Wagle. First jejunal vein, jejunal trunk, and pancreatico-duodenectomy: resolving the literature conundrumLangenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02849-w
5
Alessandro Cucchetti, Stefano Crippa, Elton Dajti, Cecilia Binda, Carlo Fabbri, Massimo Falconi, Giorgio Ercolani. Trial sequential analysis of randomized controlled trials on neoadjuvant therapy for resectable pancreatic cancerEuropean Journal of Surgical Oncology 2022; 48(9): 1994 doi: 10.1016/j.ejso.2022.04.011